Health - Physicians latest news

Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing new drugs for the treatment of unmet medical needs, announced today that it has begun to enroll patients in a Phase I/II clinical trial of its lead drug candidate trans sodium crocetinate (TSC). (Source: News-Medical News Feed)

UCB announced today that the European Commission (EC) has approved Vimpat (lacosamide) as adjunctive therapy in the treatment of partial-onset seizures with or without secondary generalisation in patients with epilepsy aged 16 years and older. Vimpat is the first new antiepileptic drug (AED) for partial-onset seizures in three years and offers a new treatment option for European patients living with uncontrolled partial-onset epilepsy. (Source: News-Medical News Feed)

Married couples in their later years often show a great deal of affection,says best-selling author Maggie Scarf, 77, who has ...

Sick Americans who travel far or frequently to get medical treatment are skipping or delaying appointments, leaving support groups ...

Hurricane Gustav created a critical need for overnight shelters, food supplies and emotional support. To swiftly respond following Gusta's landfall along the Gulf Coast, the American Red Cross moved disaster relief supplies that were pre-positioned near Texas, Louisiana, Mississippi and Alabama for hurricane season 2008.

With close to 800,000 people without power and many with wind and water damage, Hurricane Gustav continues to make life hard for the people of the Gulf Coast. After the storm, the American Red Cross is offering assistance and information to keep people safe as clean-up efforts begin. The Red Cross will provide emergency assistance in the following ways: 1.

BMA Scotland welcomed the First Minister's announcement that the Scottish government is to bring forward a health Bill which will include measures to close the legal loophole that will prevent commercial companies providing GP services in Scotland.

New analyses presented during the annual congress of the European Society of Cardiology (ESC) on the effects of cardiac resynchronisation therapy (CRT) in patients with mild heart failure from the REVERSE (Resynchronisation Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial show impr

Agile Therapeutics, Inc., announced that it successfully completed two key clinical trials in the development of the company's new, innovative low-dose, once-weekly, contraceptive patch, which the company refers to by its internal product code AG-200-15. The Phase 2b safety and efficacy study successfully met its primary endpoint of ovulation suppression, cycle control and safety.

A radioactive tracer that "lights up" cancer hiding inside dense breasts showed promise in its first big test against mammograms, revealing more tumors and giving fewer false alarms, doctors reported Wednesday....